132 studies found for:    "juvenile idiopathic arthritis" OR "Arthritis, Juvenile Rheumatoid"
Show Display Options
Download search resultsDownload the search results for:
"juvenile idiopathic arthritis" OR "Arthritis, Juvenile Rheumatoid" (132 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed Ultrasonography in Juvenile Idiopathic Arthritis
Conditions: Juvenile Idiopathic Arthritis, Oligoarthritis;   Polyarticular Juvenile Rheumatoid Arthritis;   Systemic Juvenile Idiopathic Arthritis
Intervention: Device: Ultrasonography
2 Completed
Has Results
Trial of Early Aggressive Drug Therapy in Juvenile Idiopathic Arthritis
Conditions: Juvenile Chronic Polyarthritis;   Juvenile Idiopathic Arthritis;   Juvenile Rheumatoid Arthritis
Interventions: Drug: methotrexate;   Drug: methotrexate - etanercept - prednisolone arm
3 Active, not recruiting Juvenile Idiopathic Arthritis (JIA) Registry
Conditions: Juvenile Idiopathic Arthritis;   JIA
Interventions: Biological: adalimumab;   Drug: Methotrexate
4 Completed Safety and Effectiveness of Rilonacept for Treating Systemic Juvenile Idiopathic Arthritis in Children and Young Adults
Condition: Juvenile Idiopathic Arthritis
Intervention: Biological: Rilonacept
5 Not yet recruiting Cost of Care for Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention:
6 Terminated
Has Results
A Study of the Safety and Efficacy of CNTO 148 (Golimumab) in Children With Juvenile Idiopathic Arthritis (JIA) and Multiple Joint Involvement Who Have Poor Response to Methotrexate (GO KIDS)
Condition: Juvenile Idiopathic Arthritis
Interventions: Drug: CNTO 148 (Golimumab);   Drug: Placebo;   Drug: Methotrexate
7 Completed Active Juvenile Idiopathic Arthritis (JIA)Compassionate Use
Condition: Juvenile Idiopathic Arthritis
Intervention: Drug: Adalimumab
8 Not yet recruiting Pharmacovigilance in Juvenile Idiopathic Arthritis Patients Treated With Biologic Agents and/or Methotrexate
Condition: Juvenile Idiopathic Arthritis
Intervention:
9 Not yet recruiting Massage Therapy in Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Interventions: Other: Massage therapy;   Other: Standard care
10 Recruiting Effective Dose of Etanercept in Patients Treated for Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Genetic: Blood test
11 Unknown  Study of Antibodies to Anti-TNF Agents in Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention:
12 Completed Effect of Whole Body Vibration Therapy in Children With Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Device: Galileo (whole body vibration (WBV) therapy)
13 Unknown  Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Interventions: Drug: Infliximab plus methotrexate;   Drug: Combination of DMARDs;   Drug: Methotrexate alone
14 Terminated
Has Results
Single-dose Study to Assess Efficacy of Canakinumab (ACZ885) in Patients With Active Juvenile Idiopathic Arthritis (SJIA)
Condition: Systemic Juvenile Idiopathic Arthritis
Interventions: Drug: Canakinumab;   Drug: Placebo
15 Recruiting An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever.
Condition: Systemic Juvenile Idiopathic Arthritis
Intervention: Drug: Canakinumab
16 Not yet recruiting An Open-label, Multi-arm, Non-comparative Safety and Tolerability Study of Canakinumab (ACZ885) in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)
Condition: Systemic Juvenile Idiopathic Arthritis
Interventions: Drug: Canakinumab - Cohort 1;   Drug: Canakinumab - Cohort 2
17 Unknown  Juvenile Rheumatoid Arthritis Research Registry
Condition: Juvenile Rheumatoid Arthritis
Intervention:
18 Completed Interleukin-1 Receptor Antagonist (IL-1RA) (ANAKINRA) IN SEVERE SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS
Condition: Systemic-Onset Juvenile Idiopathic Arthritis
Interventions: Drug: Anakinra;   Biological: Pneumo23
19 Terminated Infliximab to Treat Children With Juvenile Rheumatoid Arthritis
Condition: Juvenile Rheumatoid Arthritis
Intervention: Drug: Infliximab
20 Completed
Has Results
Flare Prevention Study of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)
Condition: Systemic Juvenile Idiopathic Arthritis With Active Flare
Interventions: Drug: canakinumab;   Drug: placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years